At a glance: Rhodiola, Rhodiola rosea L., is a cold-climate Crassulaceae plant whose rhizome and root are used medicinally. It has a long northern Eurasian tradition as a tonic for endurance, resilience and fatigue and is one of the best-known modern adaptogens. Modern trials have investigated mental fatigue, stress and performance with mixed but generally promising results.[1][2]
Botanical profile
- Accepted name: Rhodiola rosea L.
- Common names: rhodiola, roseroot, golden root, Arctic root.
- Family: Crassulaceae.
- Medicinal parts: rhizome and root.
Major constituent groups
Important constituents include phenylpropanoid glycosides such as rosavin, rosarin and rosin; salidroside and tyrosol; flavonoids and proanthocyanidins; phenolic acids; and volatile constituents. Rosavins are often used as markers for R. rosea products.
Traditional use
Rhodiola has traditionally been used across Scandinavia, Russia and northern Asia to increase stamina, work capacity and resilience during physical hardship, cold exposure and long periods of exertion. It has also been used for fatigue, weakness, convalescence, low mood and reduced concentration.
Contemporary herbal practice
Modern herbalists usually use rhodiola as a relatively activating adaptogen for fatigue, reduced concentration and stress-related loss of performance rather than as a simple stimulant. It is often chosen when a person feels depleted but still needs mental or physical function during sustained demands. Timing and dose matter in practice because some people find it too activating late in the day, and it may be combined with gentler nervines or restorative adaptogens according to the individual.
Adaptogen concept and research
Rhodiola is one of the classic herbs around which the modern adaptogen concept developed. Proposed effects involve stress-response pathways, HPA-axis signalling, stress proteins, monoamines and cellular energy regulation.[3]
Mental fatigue, stress and performance
Clinical studies have examined rhodiola in stress, fatigue, burnout-like symptoms and reduced mental performance. The literature includes positive trials, but differences in extract standardisation, trial quality and outcome measures prevent one universal effect size from being assigned to all products.
Preparations
Modern products are commonly dry or liquid extracts of rhizome and root. Many commercial preparations specify rosavins and salidroside; a label giving only a crude milligram amount is less informative.
Safety
Rhodiola is generally reported as well tolerated in short-term use. Possible adverse effects include headache, dizziness, gastrointestinal disturbance, agitation or sleep disruption in susceptible people.
Student note: common evidence traps
- Do not confuse Rhodiola rosea with other Rhodiola species.
- Record extract standardisation.
- “Adaptogen” is a pharmacological concept, not a diagnosis.
- Do not turn a stress/fatigue indication into a claim for every cause of chronic fatigue.
- Performance studies in healthy volunteers are not the same evidence as trials in stressed or fatigued patients.
References
- European Medicines Agency. Rhodiolae roseae rhizoma et radix. Revised EU herbal monograph and assessment report.
- EMA final revised herbal monograph on Rhodiola rosea, 2024.
- Panossian A, Wikman G. Evidence-based efficacy of adaptogens in fatigue and mechanisms related to stress-protective activity.
Additional materia medica sources
- Winston D, Maimes S. Adaptogens: Herbs for Strength, Stamina, and Stress Relief. 2nd ed. Healing Arts Press; 2019.
- Mills S, Bone K. Principles and Practice of Phytotherapy. 2nd ed. Elsevier; 2013, for adaptogen and constitutional prescribing principles.
- Panossian A, Wikman G. Modern adaptogen literature, read alongside the traditional northern Eurasian use recorded in pharmacognosy sources.
Last reviewed: 20 September 2026. Educational reference only; not an individual fatigue or prescribing guide.
← Return to the Herbal Monograph Library | Herbal Medicine Safety and Interactions